You are here

P&T News

October 24

100% of patients respond to treatment within 24 hours
Treating inflammation may be bad idea, authors say
If approved, product’s launch expected in second quarter, 2015

October 23

Capsules reduce exogenous insulin requirements in mid-stage trial
Electronic health records increase docs’ bureaucratic burden, authors say
Absence of single gene drives inflammation
Noninvasive method detects compounds produced by Aspergillus fungi

October 22

Authors recommend bundled payments for hospitals and physicians
TB/HIV co-epidemic poses key challenge
Researchers see possibility of vaccine for heart disease

October 21

Reference pricing aims to cut costs
Safety involves three key principles
Experts anticipate launch of first therapies for geographic atrophy

October 20

Morphine/naltrexone combo expected to reduce oral abuse when crushed
Disease ignored by public, neglected by doctors, experts say
Flexible custom mask covers hollow eye socket at lower cost

October 17

Studies will prepare vaccine candidate for clinical trials
Top-line results released in NIH-funded comparison of effectiveness
British research focused on the role of enzymes in bacteria
Progressive scarring of lungs leaves patients short of breath

October 16

Medications and nonpharmacologic recommendations graded
Longer period might be needed to prevent virus spread, expert says
New data support efficacy of chimeric antigen receptor therapy

October 15

Novel antipsychotic and improved rescue therapy take center stage by 2023
Replaceable device allows urination without catheterization
Additional exposures were expected, agency says

October 14

Soliris takes the prize at nearly $537,000 per year
Modified sulfonylurea stimulates insulin release
Drug’s effect on weight change, sexual function similar to that of placebo
Approval decision expected in April 2015

October 13

Drug’s effect on weight change, sexual function similar to that of placebo

October 13

Health care worker is first to develop disease in U.S.
Harvard discovery could help prevent clotting and infections
Certain patients with genotype-1 infections need just 8 weeks of treatment



From Sovaldi to Ebola: A Wide-ranging Interview with Dr. David Nash

A leading authority on population health, Dr. David Nash is optimistic about the future of disruptive innovation to improve healthcare in the U.S. The interview was conducted by P&T Editor Sonja Sherritze.



Nashville, TN
November 3 to November 4
Brussels, Belgium
November 12 to November 14

Free App

MediMedia App IconManaged Care, and P&T are available for free on multiple mobile platforms and devices. For Apple and iOS devices, visit the Apple Store and download the free digital application for Managed Care and P&T. Search for "Managed Care," "Pharmacy and Therapeutics," or "MediMedia."

Users of Android, Blackberry, Nook, and Kindle can view the mobile version on their respective devices by visiting these Web sites: Managed Care and P&T.